Home › NDC Lookup › RxCUI directory › RxCUI 833139

Milnacipran hydrochloride 100 MG Oral Tablet [Savella] — RxCUI 833139

Name: Milnacipran hydrochloride 100 MG Oral Tablet [Savella] (RxCUI 833139)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 833139 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI833139

Official nameMilnacipran hydrochloride 100 MG Oral Tablet [Savella]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asSavella 100 MG Oral Tablet

FDA products mapped5

Package NDCs mapped5

Reported Medicaid activity (SDUD)28,086 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Milnacipran: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Great question, because it's a common source of confusion. Milnacipran belongs to a class of drugs called SNRIs, which are also used to treat depression — but milnacipran itself is...
What exactly is milnacipran used for — is it an antidepressant?
Yes, nausea is the most common side effect, but there's a practical tip: try taking your tablet with food. The label specifically notes that taking milnacipran with food can help i...
Nausea seems really common with this medication — is there anything I can do about it?

📖 Read our full Milnacipran guide →

🕸️ Concept Web — How Milnacipran hydrochloride 100 MG Oral Tablet [Sa... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Milnacipran hydrochloride 100 MG Oral Tablet [Savella] RxCUI 833139 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Milnacipran 588250 IN
- Milnacipran hydrochloride 30003 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Savella 833136 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Milnacipran Oral Tablet 833134 SCDF
- Milnacipran hydrochloride Oral Tablet 2646511 SCDFP
- Milnacipran Oral Product 1157278 SCDG
- Milnacipran Pill 1157279 SCDG
- Milnacipran hydrochloride Oral Product 2659821 SCDGP
- Milnacipran hydrochloride Pill 2660203 SCDGP
- Milnacipran Oral Tablet [Savella] 833138 SBDF
- Milnacipran hydrochloride Oral Tablet [Savella] 2656132 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Milnacipran hydrochloride 100 MG Oral Tablet 833135 SCD
- Milnacipran hydrochloride 100 MG 833133 SCDC
- Milnacipran hydrochloride 100 MG [Savella] 833137 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Milnacipran hydrochloride 100 MG Oral Tablet SCD · 833135
Milnacipran hydrochloride 100 MG SCDC · 833133
Milnacipran Oral Tablet SCDF · 833134
Milnacipran hydrochloride Oral Tablet SCDFP · 2646511
Milnacipran Oral Product SCDG · 1157278
Milnacipran Pill SCDG · 1157279
Milnacipran hydrochloride Oral Product SCDGP · 2659821
Milnacipran hydrochloride Pill SCDGP · 2660203

Brand-Name Concepts

Milnacipran hydrochloride 100 MG [Savella] SBDC · 833137
Milnacipran Oral Tablet [Savella] SBDF · 833138
Milnacipran hydrochloride Oral Tablet [Savella] SBDFP · 2656132
Savella Oral Product SBDG · 1177182
Savella Pill SBDG · 1177183
Savella BN · 833136

📦 FDA Products & Package NDCs

5 products · 5 package NDCs

5 package NDCs map to RxCUI 833139 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00456-1500-55	1 BLISTER PACK in 1 CARTON (0456-1500-55) / 1 KIT in 1 BLIS...	Savella	Allergan, Inc.	2009-04-17
00456-1510-60	60 TABLET, FILM COATED in 1 BOTTLE (0456-1510-60)	Savella	Allergan, Inc.	2009-04-17
00456-1512-60	60 TABLET, FILM COATED in 1 BOTTLE (0456-1512-60)	Savella	Allergan, Inc.	2009-04-17
00456-1525-60	60 TABLET, FILM COATED in 1 BOTTLE (0456-1525-60)	Savella	Allergan, Inc.	2009-04-17
00456-1550-60	60 TABLET, FILM COATED in 1 BOTTLE (0456-1550-60)	Savella	Allergan, Inc.	2009-04-17

Observed labelers: Allergan, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.